Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 43.68B | 40.18B | 37.16B | 34.07B | 37.62B | 29.08B |
Gross Profit | 21.66B | 21.76B | 18.49B | 18.22B | 25.66B | 15.65B |
EBITDA | 17.26B | 20.73B | 11.81B | 9.07B | 14.08B | 11.33B |
Net Income | 6.63B | 10.38B | 4.55B | 2.65B | 5.65B | 6.39B |
Balance Sheet | ||||||
Total Assets | 274.96B | 289.87B | 267.06B | 270.22B | 188.30B | 178.97B |
Cash, Cash Equivalents and Short-Term Investments | 29.39B | 29.83B | 15.97B | 23.62B | 16.53B | 14.33B |
Total Debt | 73.47B | 78.24B | 63.15B | 61.15B | 46.14B | 49.10B |
Total Liabilities | 156.21B | 167.87B | 154.59B | 159.19B | 111.89B | 105.22B |
Stockholders Equity | 118.71B | 121.86B | 112.33B | 110.50B | 76.12B | 73.48B |
Cash Flow | ||||||
Free Cash Flow | 13.65B | 9.29B | 4.12B | -24.35B | -10.92B | 1.80B |
Operating Cash Flow | 16.13B | 12.39B | 8.24B | 9.28B | -8.23B | 4.20B |
Investing Cash Flow | -1.66B | -8.66B | 827.04M | -28.80B | 123.99M | 2.44B |
Financing Cash Flow | -9.89B | 9.80B | -6.76B | 30.07B | -8.45B | -6.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $18.17B | 15.77 | 6.01% | 7.88% | 6.41% | 37.23% | |
77 Outperform | $17.67B | 14.28 | 6.01% | 7.86% | 6.41% | 37.23% | |
72 Outperform | $16.70B | 19.96 | 8.55% | 3.69% | 3.28% | 13.56% | |
72 Outperform | $21.86B | 21.55 | 12.48% | 2.93% | 8.25% | 4.37% | |
72 Outperform | $21.69B | 8.28 | 17.37% | 5.87% | 4.26% | 173.18% | |
71 Outperform | $16.97B | 20.40 | 11.94% | 2.99% | 4.62% | 32.23% | |
66 Neutral | ¥392.50B | 13.52 | 9.30% | 2.53% | 3.85% | 9.47% |